Scholars Central

Conference abstractPublished 7 Nov 2016

Epigenomic profile in dementia-related disorders

Authors: Oscar Teijido Hermida, Juan C Carril, Ivan Tellado, Ramon Cacabelos

EuroEspes Biomedical Research Center, Spain Camilo Jose Cela University, Spain

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cerebrovascular and neurodegenerative disorders are among the leading causes of death in the World, according to the WHO. A number of these disorders are characterized by the onset of dementia. AlzheimerâÂ?Â?s disease (AD) is the major cause of dementia in Western countries, affecting 45-60% of the population, followed by vascular dementia (VD) and mixed dementia (MD) with prevalence of 30-40% and 10-20%, respectively. Epigenomic mechanisms (DNA methylation, chromatin remodeling/histone modifications, miRNA regulation) are involved in the transcriptional and post-translational regulation of genes in physiological and pathological conditions leading to potentially reversible phenotypes. Epigenetics is sited among the major regulatory elements that control metabolic pathways at the molecular level, which allows a deeper study of complex multifactorial diseases, such as dementia-related disorders. Therefore, epigenomic signatures may help in the prediction, early diagnosis and prognosis of those pathologies. Human exome sequencing and genome-wide association studies have linked several neurobiological disorders to epigenetically regulated genes. We have evaluated the main epigenetic mechanisms affecting genes associated with dementia-related disorders such as AlzheimerâÂ?Â?s disease (AD), dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD). We also evaluated genes related with lipid metabolism and vascular physiology which are not directly involved in brain disorders, although their epigenetic profile may be nevertheless associated with dementia-related disorders. Epigenetic drug discovery, application of pharmacoepigenomic procedures for personalized therapeutics, novel approaches to decode and resolve drug resistance and targeting miRNAs in prevention and treatment of dementia-related disorders are promising areas of future development.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Human Genetics & Embryology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHuman Genetics & Embryology
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Oscar Teijido Hermida”
  • BylineArticles whose byline prints “Juan C Carril”
  • BylineArticles whose byline prints “Ivan Tellado”
  • BylineArticles whose byline prints “Ramon Cacabelos”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels